Assignee profile:

MolMed SpA

City:

Milan

Country:

Italy

Published Applications:

18

Last publication date:

2020-05-28

Patent Grants:

14

Last grant date:

2019-06-11

Top Inventors for applications by MolMed SpA

These are the the leading inventors for applications assigned to MolMed SpA:

Recent patent applications by MolMed SpA

MolMed SpA based in Milan, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-05-28
US20200165629A1
Chemistry; metallurgy

STABLE INTEGRATION OF SIN TRANFER VECTORS

#2 | 2019-03-07 ✅ Patent 10,314,925 granted on 2019-06-11
US20190070312A1
Human necessities

Thymidine kinase

#3 | 2018-01-04 ✅ Patent 10,144,937 granted on 2018-12-04
US20180002721A1
Chemistry; metallurgy

Stable production of lentiviral vectors

#4 | 2016-03-17 ✅ Patent 9,782,496 granted on 2017-10-10
US20160074537A1
Human necessities

Immunoconjugates for the treatment of tumours

#5 | 2015-08-20 ✅ Patent 10,155,052 granted on 2018-12-18
US20150231275A1
Human necessities

Thymidine kinase

#6 | 2014-09-04
US20140248695A1
Chemistry; metallurgy

Viral Vectors Purification System

#7 | 2014-06-26 ✅ Patent 9,005,945 granted on 2015-04-14
US20140178345A1
Chemistry; metallurgy

Thymidine kinase

#8 | 2014-02-20 ✅ Patent 9,441,245 granted on 2016-09-13
US20140051125A1
Chemistry; metallurgy

Stable production of lentiviral vectors

#9 | 2013-11-28 ✅ Patent 9,068,016 granted on 2015-06-30
US20130315856A1
Chemistry; metallurgy

Conjugates for the treatment of mesothelioma

#10 | 2013-06-27 ✅ Patent 9,133,481 granted on 2015-09-15
US20130164840A1
Chemistry; metallurgy

Semi-stable production of lentiviral vectors

#11 | 2013-01-31 ✅ Patent 8,642,311 granted on 2014-02-04
US20130028876A1
Human necessities

Thymidine kinase

#12 | 2010-12-09 ✅ Patent 9,119,886 granted on 2015-09-01
US20100310506A1
Human necessities

Immunoconjugates for the treatment of tumours

#13 | 2009-05-21 ✅ Patent 8,357,788 granted on 2013-01-22
US20090130069A1
Human necessities

Thymidine kinase

#14 | 2009-03-12 ✅ Patent 7,795,386 granted on 2010-09-14
US20090068106A1
Chemistry; metallurgy

Peptides comprising an isoDGR motif

#15 | 2008-11-20
US20080286305A1
Human necessities

Antigen Transduced T Cells Used as a Delivery System for Antigens

#16 | 2008-11-20 ✅ Patent 8,912,152 granted on 2014-12-16
US20080286248A1
Chemistry; metallurgy

HIV vif mutants

#17 | 2008-08-19 ✅ Patent 7,413,733 granted on 2008-08-19
US10492143
-

Antigen transduced T cells used as a delivery system for antigens

#18 | 2007-07-19
US20070166291A1
Chemistry; metallurgy

Cell preparation

Also check out MolMed SpA's (Milan, Italy) applicant profile with 5 patent applications submitted.

AssigneeID:

69401 ⎘